Rik de Wijn
Rik de Wijn publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies and Monoclonal and Polyclonal Antibodies Research.
- World rank
- #5,021,273 of 7,710,434 ranked researchers
- Rank in Netherlands
- #89,204 of 107,149
- Works
- 74
- Citations
- 463
- Citations per work
- 6.3
What does Rik de Wijn research?
Rik de Wijn's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (31%), Chemistry (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3445.3%
- Medicine3445.3%
- Life Sciences2330.9%
- Everything else1520.7%
- Physical Sciences23.1%
- Chemistry23.1%
- 1Oncology26% of their works
- 2Molecular Biology25% of their works
- 3Pulmonary and Respiratory Medicine10% of their works
- 4Radiology, Nuclear Medicine and Imaging9% of their works
- 5Cancer Research6% of their works
- 6Spectroscopy3% of their works
Research topics
Which keywords describe Rik de Wijn's research?
The keywords of their largest research topics: Chemotherapy, EGFR Mutations, Targeted Therapy, Tumor Microenvironment, Cetuximab, Fc Receptors, KRAS Mutations and Therapeutic Antibodies.
- Warburg Effect
- HIF-1
- Protein Microarrays
- HER2
- PD-1 and PD-L1
- Therapeutic Antibodies
- Fc Receptors
- Tumor Microenvironment
- EGFR Mutations
- Chemotherapy
- Targeted Therapy
- Cetuximab
- KRAS Mutations
- Immune Checkpoint Blockade
- Breast Cancer
- High-Throughput Analysis
- Bacterial Therapy
- Tumor Targeting
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Chemotherapy162 topics
- EGFR Mutations131 topic
- Targeted Therapy131 topic
- Tumor Microenvironment132 topics
- Cetuximab91 topic
- Fc Receptors91 topic
- KRAS Mutations91 topic
- Therapeutic Antibodies91 topic
- Immune Checkpoint Blockade81 topic
- PD-1 and PD-L181 topic
- Breast Cancer71 topic
- HER271 topic
- High-Throughput Analysis71 topic
- Protein Microarrays71 topic
- Bacterial Therapy51 topic
- HIF-151 topic
- Tumor Targeting51 topic
- Warburg Effect51 topic
Where does Rik de Wijn work?
Rik de Wijn's main affiliation in the publication record is PamGene (Netherlands), Netherlands.
How many publications and citations does Rik de Wijn have?
OpenAlex counts 74 works and 463 citations for Rik de Wijn, an h-index of 11, ranking #5,021,273 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rik de Wijn. Posts are plain text and can be reported.